Drug delivery systems for resveratrol, a non-flavonoid polyphenol: Emerging evidence in last decades

Journal of Drug Delivery Science and Technology

Volumn 51, Issue , 2019, Pages 591-604

  Ahmadi, Zahra ^a   Mohammadinejad, Reza ^b   Ashrafizadeh, Milad ^a  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bioavailability; Cancer therapy; Drug delivery; Nanostructures; Resveratrol

Indexed keywords

GOLD NANOPARTICLE; LIPOSOME; RESVERATROL; SILVER NANOPARTICLE; SOLID LIPID NANOPARTICLE; WATER;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; AQUEOUS SOLUTION; CHEMICAL STRUCTURE; DRUG DELIVERY SYSTEM; DRUG RELEASE; HEP-G2 CELL LINE; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; NANOTECHNOLOGY; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PHOTOSENSITIVITY; REVIEW; SUSTAINED DRUG RELEASE;

EID: 85063733150     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jddst.2019.03.017     Document Type: Review

References (140)

1. Ashrafizadeh, M., Ahmadi, Z., The effects of astaxanthin treatment on the sperm quality of mice treated with nicotine. Rev. Clin. Med. 6:1 (2019), 156–158, 10.22038/rcm.2019.37708.1252.
2. Bavarsad, K., et al. Protective effects of curcumin against ischemia-reperfusion injury in the liver. Pharmacol. Res. 141 (March 2019), 53–62.
3. Ghanaatian, F., et al. Curcumin as a therapeutic candidate for multiple sclerosis: molecular mechanisms and targets. J. Cell. Physiol., 2018, 1–12, 10.1002/jcp.27965.
4. Mokhtari‐Zaer, A., et al. The protective role of curcumin in myocardial ischemia–reperfusion injury. J. Cell. Physiol. 234:1 (2019), 214–222.
5. Mortezaee, K., et al. Mechanisms of apoptosis modulation by curcumin: implications for cancer therapy. J. Cell. Physiol., 2019, 1–14, 10.1002/jcp.28122.
6. Panahi, Y., et al. Evidence of curcumin and curcumin analogue effects in skin diseases: a narrative review. J. Cell. Physiol. 234:2 (2019), 1165–1178.
7. Yaribeygi, H., et al. Protective effects of plant‐derived natural products on renal complications. J. Cell. Physiol., 2018, 1–12, 10.1002/jcp.27950.
8. Mohammadinejad, R., et al. Berberine as a potential autophagy modulator. J. Cell. Physiol., 2019, 1–13, 10.1002/jcp.28325.
9. Mohamadi, N., et al. A review on biosynthesis, analytical techniques, and pharmacological activities of trigonelline as a plant alkaloid. J. Diet. Suppl. 15:2 (2018), 207–222.
10. Sobhani, B., et al. Histopathological analysis of testis: effects of astaxanthin treatment against nicotine toxicity. Iran. J. Toxicol. 13:1 (2019), 41–44.
11. Tabibiazar, M., et al. Improvement in dispersibility, stability and antioxidant activity of resveratrol using a colloidal nanodispersion of BSA-resveratrol. Food Biosci. 27 (February 2019), 46–53.
12. Burns, J., et al. Plant foods and herbal sources of resveratrol. J. Agric. Food Chem. 50:11 (2002), 3337–3340.
13. Jeandet, P., et al. Biosynthesis, metabolism, molecular engineering, and biological functions of stilbene phytoalexins in plants. Biofactors 36:5 (2010), 331–341.
14. Abdu, S.B., Al-Bogami, F.M., Influence of resveratrol on liver fibrosis induced by dimethylnitrosamine in male rats. Saudi J. Biol. Sci. 26:1 (January 2019), 201–209.
15. Storniolo, C.E., Moreno, J.J., Resveratrol analogs with antioxidant activity inhibit intestinal epithelial cancer Caco-2 cell growth by modulating arachidonic acid cascade. J. Agric. Food Chem. 67:3 (2019), 819–828.
16. Yin, S., et al. Dual receptor recognizing liposomes containing paclitaxel and hydroxychloroquine for primary and metastatic melanoma treatment via autophagy-dependent and independent pathways. J. Control. Release 288 (2018), 148–160.
17. Zhang, D., et al. Nano-gold loaded with resveratrol enhance the anti-hepatoma effect of resveratrol in vitro and in vivo. J. Biomed. Nanotechnol. 15:2 (2019), 288–300.
18. Zhao, H., et al. Resveratrol induces apoptosis in human melanoma cell through negatively regulating Erk/PKM2/Bcl-2 axis. OncoTargets Ther., 11, 2018, 8995.
19. Lu, Y., et al. Resveratrol attenuates high fat diet-induced mouse cardiomyopathy through upregulation of estrogen related receptor-α. Eur. J. Pharmacol. 843 (2019), 88–95.
20. Wu, B., et al. A novel resveratrol-curcumin hybrid, a19, attenuates high fat diet-induced nonalcoholic fatty liver disease. Biomed. Pharmacother. 110 (2019), 951–960.
21. Wu, J., et al. Preparation and biological activity studies of resveratrol loaded ionically cross-linked chitosan-TPP nanoparticles. Carbohydr. Polym. 175 (2017), 170–177.
22. Li, Y.R., Li, S., Lin, C.C., Effect of resveratrol and pterostilbene on aging and longevity. Biofactors 44:1 (2018), 69–82.
23. Fourny, N., et al. Protective effect of resveratrol against ischemia-reperfusion injury via enhanced high energy compounds and eNOS-SIRT1 expression in type 2 diabetic female rat heart. Nutrients, 11(1), 2019, 105.
24. Öztürk, E., et al. Resveratrol and diabetes: a critical review of clinical studies. Biomed. Pharmacother. 95 (2017), 230–234.
25. Rehman, K., et al. Resveratrol regulates hyperglycemia-induced modulations in experimental diabetic animal model. Biomed. Pharmacother. 102 (2018), 140–146.
26. Yang, D.K., Kang, H.-S., Anti-Diabetic effect of cotreatment with quercetin and resveratrol in streptozotocin-induced diabetic rats. Biomol. Ther., 26(2), 2018, 130.
27. Elmali, N., et al. Effects of resveratrol in inflammatory arthritis. Inflammation 30:1–2 (2007), 1–6.
28. Valenzano, D.R., et al. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr. Biol. 16:3 (2006), 296–300.
29. Howitz, K.T., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 425(6954), 2003, 191.
30. Alberdi, G., et al. Changes in white adipose tissue metabolism induced by resveratrol in rats. Nutr. Metabol., 8(1), 2011, 29.
31. Fernández‐Quintela, A., et al. Antiobesity effects of resveratrol: which tissues are involved?. Ann. N. Y. Acad. Sci. 1403:1 (2017), 118–131.
32. Hamza, R.Z., El-Shenawy, N.S., Anti-inflammatory and antioxidant role of resveratrol on nicotine-induced lung changes in male rats. Toxicol. Rep. 4 (2017), 399–407.
33. Jimoh, A., et al. Resveratrol prevents high-fat diet-induced obesity and oxidative stress in rabbits. Pathophysiology 25:4 (December 2018), 359–364.
34. Oliveira, A., et al. Resveratrol role in autoimmune disease—a mini-review. Nutrients, 9(12), 2017, 1306.
35. Carter, L.G., D'Orazio, J.A., Pearson, K.J., Resveratrol and Cancer: a Focus on in Vivo Evidence. 2014, Endocrine-related cancer ERC-13-0171.
36. Davidov-Pardo, G., McClements, D.J., Resveratrol encapsulation: designing delivery systems to overcome solubility, stability and bioavailability issues. Trends Food Sci. Technol. 38:2 (2014), 88–103.
37. Elgebaly, A., et al. Resveratrol supplementation in patients with non-alcoholic fatty liver disease: systematic review and meta-analysis. J. Gastrointest. Liver Dis., 26(1), 2017.
38. Empl, M.T., et al. Effects of a grapevine shoot extract containing resveratrol and resveratrol oligomers on intestinal adenoma development in mice: in vitro and in vivo studies. Mol. Nutr. Food Res., 62(2), 2018, 1700450.
39. Ajdary, M., et al. Health concerns of various nanoparticles: a review of their in vitro and in vivo toxicity. Nanomaterials, 8(9), 2018, 634.
40. Mohammadinejad, R., et al. Necrotic, apoptotic and autophagic cell fates triggered by nanoparticles. Autophagy 15:1 (2019), 4–33.
41. Nadimi, A.E., et al. Nano-scale drug delivery systems for antiarrhythmic agents. Eur. J. Med. Chem. 157 (5 September 2018), 1153–1163.
42. Song, Y., et al. Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook. Int. J. Nanomed., 12, 2017, 87.
43. Akhtartavan, S., et al. Evaluation of a self-nanoemulsifying docetaxel delivery system. Biomed. Pharmacother. 109 (2019), 2427–2433.
44. Ranjbar, M., et al. Efficient drug delivery of β-estradiol encapsulated in Zn-metal–organic framework nanostructures by microwave-assisted coprecipitation method. Drug Des. Dev. Ther., 12, 2018, 2635.
45. Mohammadinejad, R., et al. Shedding light on gene therapy: carbon dots for the minimally invasive image-guided delivery of plasmids and noncoding RNAs. J. Adv. Res. 18 (July 2019), 81–93.
46. Mohammadinejad, R., et al. Plant-derived nanostructures: types and applications. Green Chem. 18:1 (2016), 20–52.
47. Watermann, A., Brieger, J., Mesoporous silica nanoparticles as drug delivery vehicles in cancer. Nanomaterials, 7(7), 2017, 189.
48. Mirhadi, E., Rezaee, M., Malaekeh-Nikouei, B., Nano strategies for berberine delivery, a natural alkaloid of Berberis. Biomed. Pharmacother. 104 (2018), 465–473.
49. Masood, F., Polymeric nanoparticles for targeted drug delivery system for cancer therapy. Mater. Sci. Eng. C 60 (2016), 569–578.
50. Nassir, A.M., et al. Resveratrol-loaded PLGA nanoparticles mediated programmed cell death in prostate cancer cells. Saudi Pharmaceut. J. 26:6 (September 2018), 876–885.
51. Suktham, K., et al. Efficiency of resveratrol-loaded sericin nanoparticles: promising bionanocarriers for drug delivery. Int. J. Pharm. 537:1–2 (2018), 48–56.
52. Song, Z., et al. Endothelial growth factor receptor-targeted and reactive oxygen species-responsive lung cancer therapy by docetaxel and resveratrol encapsulated lipid-polymer hybrid nanoparticles. Biomed. Pharmacother. 105 (2018), 18–26.
53. Al-Attar, T., Madihally, S.V., Influence of controlled release of resveratrol from electrospun fibers in combination with siRNA on leukemia cells. Eur. J. Pharm. Sci. 123 (2018), 173–183.
54. Borges, S.C., et al. Evaluation of the treatment with resveratrol-loaded nanoparticles in intestinal injury model caused by ischemia and reperfusion. Toxicology 396 (2018), 13–22.
55. Chanphai, P., Tajmir-Riahi, H., Probing the binding of resveratrol, genistein and curcumin with chitosan nanoparticles. J. Mol. Liq. 243 (2017), 108–114.
56. Siu, F.Y., et al. Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity. Int. J. Nanomed., 13, 2018, 4133.
57. Vijayakumar, M.R., et al. Resveratrol loaded PLGA: D-α-tocopheryl polyethylene glycol 1000 succinate blend nanoparticles for brain cancer therapy. RSC Adv. 6:78 (2016), 74254–74268.
58. Fonseca, D.P., Khalil, N.M., Mainardes, R.M., Bovine serum albumin-based nanoparticles containing resveratrol: characterization and antioxidant activity. J. Drug Deliv. Sci. Technol. 39 (2017), 147–155.
59. Jung, K.-H., et al. Resveratrol-loaded polymeric nanoparticles suppress glucose metabolism and tumor growth in vitro and in vivo. Int. J. Pharm. 478:1 (2015), 251–257.
60. Natesan, S., et al. Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: for efficient intra ocular pressure reduction. Int. J. Biol. Macromol. 104 (2017), 1837–1845.
61. Kumar, S., et al. Biocompatible PLGA-oil hybrid nanoparticles for high loading and controlled delivery of resveratrol. J. Drug Deliv. Sci. Technol. 30 (2015), 54–62.
62. Musazzi, U.M., et al. Resveratrol-loaded nanocarriers: formulation, optimization, characterization and in vitro toxicity on cochlear cells. Colloids Surfaces B Biointerfaces 118 (2014), 234–242.
63. Kumar, S., Lather, V., Pandita, D., A facile green approach to prepare core-shell hybrid PLGA nanoparticles for resveratrol delivery. Int. J. Biol. Macromol. 84 (2016), 380–384.
64. Shen, J., et al. Resveratrol delivery by ultrasound-mediated nanobubbles targeting nucleus pulposus cells. Nanomedicine(0), 2018.
65. Zhang, L., et al. Alginate-shelled SPI nanoparticle for encapsulation of resveratrol with enhanced colloidal and chemical stability. Food Hydrocolloids 90 (2019), 313–320.
66. Tabibiazar, M., et al. Improvement in dispersibility, stability and antioxidant activity of resveratrol using a colloidal nanodispersion of BSA-resveratrol. Food Biosci. 27 (2019), 46–53.
67. Santos, A.C., et al. First-time orally administered resveratrol-loaded Layer-by-Layer nanoparticles to rats–a pharmacokinetics study. Analyst, 2019, 10.1039/C8AN01998C.
68. Iglesias, N., et al. Nanostructured chitosan-based biomaterials for sustained and colon-specific resveratrol release. Int. J. Mol. Sci., 20(2), 2019, 398.
69. Zhang, F., et al. Co-encapsulation of α-tocopherol and resveratrol within zein nanoparticles: impact on antioxidant activity and stability. J. Food Eng. 247 (2019), 9–18.
70. Wan, S., et al. Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy. Roy. Soc. Open Sci., 5(11), 2018, 181457.
71. Yingchoncharoen, P., Kalinowski, D.S., Richardson, D.R., Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come. Pharmacol. Rev. 68:3 (2016), 701–787.
72. Daraee, H., et al. Application of liposomes in medicine and drug delivery. Artif. Nanomed. Biotechnol. 44:1 (2016), 381–391.
73. Sercombe, L., et al. Advances and challenges of liposome assisted drug delivery. Front. Pharmacol., 6, 2015, 286.
74. Pattni, B.S., Chupin, V.V., Torchilin, V.P., New developments in liposomal drug delivery. Chem. Rev. 115:19 (2015), 10938–10966.
75. Sætern, A.M., Flaten, G.E., Brandl, M., A method to determine the incorporation capacity of camptothecin in liposomes. AAPS PharmSciTech 5:3 (2004), 30–37.
76. Askarizadeh, A., et al. Liposomal nanocarriers for statins: a pharmacokinetic and pharmacodynamics appraisal. J. Cell. Physiol. 234:2 (2019), 1219–1229.
77. Shishir, M.R.I., et al. Liposomal delivery of natural product: a promising approach in health research. Trends Food Sci. Technol. 85 (March 2019), 177–200.
78. Caddeo, C., et al. Stability, biocompatibility and antioxidant activity of PEG-modified liposomes containing resveratrol. Int. J. Pharm. 538:1–2 (2018), 40–47.
79. Ethemoglu, M., et al. Anticonvulsant activity of resveratrol-loaded liposomes in vivo. Neuroscience 357 (2017), 12–19.
80. Jhaveri, A., et al. Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma. J. Control. Release 277 (2018), 89–101.
81. Zu, Y., et al. Resveratrol liposomes and lipid nanocarriers: comparison of characteristics and inducing browning of white adipocytes. Colloids Surfaces B Biointerfaces 164 (2018), 414–423.
82. Park, S.N., Jo, N.R., Jeon, S.H., Chitosan-coated liposomes for enhanced skin permeation of resveratrol. J. Ind. Eng. Chem. 20:4 (2014), 1481–1485.
83. Bonechi, C., et al. Using liposomes as carriers for polyphenolic compounds: the case of trans-resveratrol. PLoS One, 7(8), 2012, e41438.
84. Meng, J., et al. Combination therapy using co-encapsulated resveratrol and paclitaxel in liposomes for drug resistance reversal in breast cancer cells in vivo. Sci. Rep., 6, 2016, 22390.
85. Narayanan, N.K., et al. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int. J. Cancer 125:1 (2009), 1–8.
86. Csiszár, A., et al. Resveratrol encapsulated in novel fusogenic liposomes activates Nrf2 and attenuates oxidative stress in cerebromicrovascular endothelial cells from aged rats. J. Gerontol. Ser. A: Biomed. Sci. Med. Sci. 70:3 (2014), 303–313.
87. Lu, X.-Y., et al. Application of liposome encapsulation technique to improve anti-carcinoma effect of resveratrol. Drug Dev. Ind. Pharm. 38:3 (2012), 314–322.
88. Wang, Y., et al. Protective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in Parkinsonian rats. J. Neurol. Sci. 304:1–2 (2011), 29–34.
89. Wang, M., et al. Gold nanoshell coated thermo-pH dual responsive liposomes for resveratrol delivery and chemo-photothermal synergistic cancer therapy. J. Mater. Chem. B 5:11 (2017), 2161–2171.
90. Doppalapudi, S., Mahira, S., Khan, W., Development and in vitro assessment of psoralen and resveratrol co-loaded ultradeformable liposomes for the treatment of vitiligo. J. Photochem. Photobiol. B Biol. 174 (2017), 44–57.
91. Balanč B., et al. Novel resveratrol delivery systems based on alginate-sucrose and alginate-chitosan microbeads containing liposomes. Food Hydrocolloids 61 (2016), 832–842.
92. Caddeo, C., et al. Effect of quercetin and resveratrol co-incorporated in liposomes against inflammatory/oxidative response associated with skin cancer. Int. J. Pharm. 513:1–2 (2016), 153–163.
93. Cadena, P.G., et al. Nanoencapsulation of quercetin and resveratrol into elastic liposomes. Biochim. Biophys. Acta Biomembr. 1828:2 (2013), 309–316.
94. Caddeo, C., et al. Physico-chemical characterization of succinyl chitosan-stabilized liposomes for the oral co-delivery of quercetin and resveratrol. Carbohydr. Polym. 157 (2017), 1853–1861.
95. Cosco, D., et al. Ultradeformable liposomes as multidrug carrier of resveratrol and 5-fluorouracil for their topical delivery. Int. J. Pharm. 489:1–2 (2015), 1–10.
96. Xu, X., et al. Co-delivery of resveratrol and p53 gene via peptide cationic liposomal nanocarrier for the synergistic treatment of cervical cancer and breast cancer cells. J. Drug Deliv. Sci. Technol., 2018, 10.1016/j.jddst.2018.05.008.
97. Jøraholmen, M.W., et al. Resveratrol-loaded liposomes for topical treatment of the vaginal inflammation and infections. Eur. J. Pharm. Sci. 79 (2015), 112–121.
98. Vanaja, K., et al. Liposomes as carriers of the lipid soluble antioxidant resveratrol: evaluation of amelioration of oxidative stress by additional antioxidant vitamin. Life Sci. 93:24 (2013), 917–923.
99. Amirmahani, N., et al. Advances in nanomicelles for sustained drug delivery. J. Ind. Eng. Chem. 55 (2017), 21–34.
100. Movassaghian, S., Merkel, O.M., Torchilin, V.P., Applications of polymer micelles for imaging and drug delivery. Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 7:5 (2015), 691–707.
101. Biswas, S., et al. Recent advances in polymeric micelles for anti-cancer drug delivery. Eur. J. Pharm. Sci. 83 (2016), 184–202.
102. Lu, X., et al. Resveratrol-loaded polymeric micelles protect cells from Aβ-induced oxidative stress. Int. J. Pharm. 375:1–2 (2009), 89–96.
103. Cote, B., et al. Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo. J. Control. Release 213 (2015), 128–133.
104. Carlson, L.J., et al. Polymeric micellar co-delivery of resveratrol and curcumin to mitigate in vitro doxorubicin-induced cardiotoxicity. J. Pharm. Sci. 103:8 (2014), 2315–2322.
105. Washington, K.E., et al. Combination loading of doxorubicin and resveratrol in polymeric micelles for increased loading efficiency and efficacy. ACS Biomater. Sci. Eng. 4:3 (2018), 997–1004.
106. Hu, M., Zhu, J., Qiu, L., Polymer micelle-based combination therapy of paclitaxel and resveratrol with enhanced and selective antitumor activity. RSC Adv. 4:109 (2014), 64151–64161.
107. Kim, G., et al. Self-assembled polymeric micelles for combined delivery of anti-inflammatory gene and drug to the lungs by inhalation. Nanoscale 10:18 (2018), 8503–8514.
108. Beloqui, A., et al. Nanostructured lipid carriers: promising drug delivery systems for future clinics. Nanomed. Nanotechnol. Biol. Med. 12:1 (2016), 143–161.
109. Yadav, A., et al. Resveratrol loaded solid lipid nanoparticles attenuate mitochondrial oxidative stress in vascular dementia by activating Nrf2/HO-1 pathway. Neurochem. Int. 112 (2018), 239–254.
110. Chen, J., et al. Development and evaluation of resveratrol, Vitamin E, and epigallocatechin gallate loaded lipid nanoparticles for skin care applications. Eur. J. Pharm. Biopharm. 117 (2017), 286–291.
111. Jose, S., et al. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery. Int. J. Pharm. 474:1–2 (2014), 6–13.
112. Pandita, D., et al. Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol. Food Res. Int. 62 (2014), 1165–1174.
113. Ramalingam, P., Ko, Y.T., Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles. Colloids Surfaces B Biointerfaces 139 (2016), 52–61.
114. Trotta, V., et al. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles. Eur. J. Pharm. Biopharm. 127 (2018), 250–259.
115. Teskač K., Kristl, J., The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int. J. Pharm. 390:1 (2010), 61–69.
116. Loureiro, J.A., et al. Resveratrol and grape extract-loaded solid lipid nanoparticles for the treatment of Alzheimer's disease. Molecules, 22(2), 2017, 277.
117. Neves, A.R., Queiroz, J.F., Reis, S., Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E. J. Nanobiotechnol., 14(1), 2016, 27.
118. Neves, A.R., et al. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. Int. J. Nanomed., 8, 2013, 177.
119. Gokce, E.H., et al. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Int. J. Nanomed., 7, 2012, 1841.
120. Montenegro, L., et al. Resveratrol-loaded lipid nanocarriers: correlation between in vitro occlusion factor and in vivo skin hydrating effect. Pharmaceutics, 9(4), 2017, 58.
121. Shrotriya, S., Ranpise, N., Vidhate, B., Skin targeting of resveratrol utilizing solid lipid nanoparticle-engrossed gel for chemically induced irritant contact dermatitis. Drug Deliv. Transl. Res. 7:1 (2017), 37–52.
122. Serini, S., et al. Omega-3 PUFA loaded in resveratrol-based solid lipid nanoparticles: physicochemical properties and antineoplastic activities in human colorectal cancer cells in vitro. Int. J. Mol. Sci., 19(2), 2018, 586.
123. Gasco, M., Solid lipid nanospheres from warm micro-emulsions: improvements in SLN production for more efficient drug delivery. Pharmaceut. Technol. Eur. 9 (1997), 52–58.
124. Wang, W., et al. Anticancer effects of resveratrol-loaded solid lipid nanoparticles on human breast cancer cells. Molecules, 22(11), 2017, 1814.
125. Rigon, R.B., et al. Skin delivery and in vitro biological evaluation of trans-resveratrol-loaded solid lipid nanoparticles for skin disorder therapies. Molecules, 21(1), 2016, 116.
126. Neves, A.R., et al. Nanoscale delivery of resveratrol towards enhancement of supplements and nutraceuticals. Nutrients, 8(3), 2016, 131.
127. Kong, F.-Y., et al. Unique roles of gold nanoparticles in drug delivery, targeting and imaging applications. Molecules, 22(9), 2017, 1445.
128. Kamal, R., Chadha, V.D., Dhawan, D., Physiological uptake and retention of radiolabeled resveratrol loaded gold nanoparticles (99mTc-Res-AuNP) in colon cancer tissue. Nanomed. Nanotechnol. Biol. Med. 14:3 (2018), 1059–1071.
129. Park, S., et al. Antibacterial nanocarriers of resveratrol with gold and silver nanoparticles. Mater. Sci. Eng. C 58 (2016), 1160–1169.
130. Kumar, C.G., Poornachandra, Y., Mamidyala, S.K., Green synthesis of bacterial gold nanoparticles conjugated to resveratrol as delivery vehicles. Colloids Surfaces B Biointerfaces 123 (2014), 311–317.
131. Mohanty, R.K., Thennarasu, S., Mandal, A.B., Resveratrol stabilized gold nanoparticles enable surface loading of doxorubicin and anticancer activity. Colloids Surfaces B Biointerfaces 114 (2014), 138–143.
132. Tomoaia, G., et al. Effects of doxorubicin mediated by gold nanoparticles and resveratrol in two human cervical tumor cell lines. Colloids Surfaces B Biointerfaces 135 (2015), 726–734.
133. A Santos, H., et al. Mesoporous materials and nanocrystals for enhancing the dissolution behavior of poorly water-soluble drugs. Curr. Pharmaceut. Biotechnol. 14:10 (2013), 926–938.
134. Jambhrunkar, S., et al. Modulating in vitro release and solubility of griseofulvin using functionalized mesoporous silica nanoparticles. J. Colloid Interface Sci. 434 (2014), 218–225.
135. Niu, Y., et al. Recent advances in the rational design of silica-based nanoparticles for gene therapy. Ther. Deliv. 3:10 (2012), 1217–1237.
136. Pérez‐Esteve, É., et al. Mesoporous silica‐based supports for the controlled and targeted release of bioactive molecules in the gastrointestinal tract. J. Food Sci. 80:11 (2015), E2504–E2516.
137. Popat, A., et al. Programmable drug release using bioresponsive mesoporous silica nanoparticles for site-specific oral drug delivery. Chem. Commun. 50:42 (2014), 5547–5550.
138. Summerlin, N., et al. Colloidal mesoporous silica nanoparticles enhance the biological activity of resveratrol. Colloids Surfaces B Biointerfaces 144 (2016), 1–7.
139. Li, J., et al. Preparation and characterization of pelletized solid dispersion of resveratrol with mesoporous silica microparticles to improve dissolution by fluid-bed coating techniques. Asian J. Pharm. Sci. 11:4 (2016), 528–535.
140. Juère, E., et al. In vitro dissolution, cellular membrane permeability, and anti-inflammatory response of resveratrol-encapsulated mesoporous silica nanoparticles. Mol. Pharm. 14:12 (2017), 4431–4441.